Full Press Release Details
Corporation and Data Knights Acquisition Corp. Announce Effectiveness of Registration Statement and Date of Data Knights' Special
Meeting to Approve Proposed Business Combination
Data Knights Acquisition Corp. Stockholder to Approve Business Combination Scheduled for October 17, 2023
of Record as of September 20, 2023, are Eligible to Vote at Special Meeting
Upon Closing, the Combined
Company is Expected to Trade on Nasdaq Under the Ticker "ONMD"
Minneapolis, MN and London, UK - September
25, 2023 - OneMedNet Corporation, the leading curator of regulatory-grade Imaging Real Word Data ("iRWDTM")
and Data Knights Acquisition Corp. ("Data Knights" or "DKAC") (Nasdaq: DKDCA, DKDCW), a publicly-traded special
purpose acquisition company, today announced that the Securities and Exchange Commission ("SEC") has declared effective the
registration Statement on Form S-4 ("Registration Statement") in connection with OneMedNet
and Data Knights' previously announced proposed business combination (the "Business Combination"). The
Registration Statement provides important information about OneMedNet, DKAC and the Business Combination.
Data Knights also announced that it will hold
a special meeting of its stockholders virtually via live webcast at https://www.cstproxy.com/dataknights/2023 on October 17, 2023
at 10 a.m. Eastern Time (the "Special Meeting") for its stockholders of record as of the close of business on September 20,
2023 (the "Record Date"), at which Data Knights' shareholders will be asked to
consider and vote upon proposals to approve the Business Combination and related matters. Data Knights will also file a definitive
proxy statement/prospectus with the SEC relating to the Business Combination and will commence mailing the definitive proxy statement/prospectus
to its stockholders as of the Record Date as soon as practicable. The Business Combination is expected to close shortly after the special
meetings of the stockholders of Date Knights and OneMedNet, subject to the approval of the stockholders of each of Data Knights and OneMedNet
Combination is expected to close shortly after the Special Meeting, subject to shareholder approvals and the satisfaction or waiver of
the conditions in the business combination agreement and other customary closing conditions. Upon closing of the Business Combination,
the post-closing company will be renamed "OneMedNet Corporation" and its common stock and warrants are expected to trade on
The Nasdaq Stock Market, LLC ("Nasdaq") under the ticker symbols "ONMD" and "ONMD," respectively.
Paul Casey, Chief Executive Officer of OneMedNet,
commented, "We are excited to announce the near completion of our path to becoming a publicly traded company. Upon the closing of
this transaction, investors now have the opportunity to invest in OneMedNet's mission of providing research and regulatory-ready,
image-centric data that our competitors cannot."
Barry Anderson, Founder and Chief Executive Officer
of Data Knights, said "With the receipt of notice from the SEC informing us of the effectiveness of our S-4 Registration, we are
excited to watch OneMedNet become a publicly traded company and act on its plan to increase value for our stockholders."
and Data Knights previously announced, on April 25, 2022, their execution of a definitive Business Combination agreement. OneMedNet's
innovation solutions connect healthcare providers and patients, offering direct access to clinical images and associated contextual patient
record. OneMedNet proved the commercial and regulatory viability of imaging RWD, a promising emerging market, and provides regulatory-grade
image-centric RWD that exactly matches OneMedNet's Life Science Partners' Case Selection Protocol. With a growing federated network of
200+ healthcare systems and providers, OneMedNet has the immediate ability to search and extensively curate multi-layer data from a Federated
group of healthcare facilities quickly and proficiently.
stockholders are urged to read the proxy materials, including, among other things, the reasons for the unanimous recommendation by Data
Knight's Board of Directors that stockholders vote "FOR" the Business Combination proposal. Your vote "FOR"
the Business Combination is important, no matter how many shares you own. If you have any questions or need assistance voting, please
contact Laurel Hill Advisory Group, LLC, Data Knight's proxy solicitor, by telephone
at (855) 414-2266 or by email at dataknights@laurelhill.com.
Data Knights stockholders who hold shares in "street name" (i.e., stockholders whose shares are held of record by a broker,
bank, or other nominee) should contact their broker, bank, or nominee to ensure that their shares are voted.
About OneMedNet Corporation
Founded in 2009, OneMedNet unlocks the significant
value contained within the clinical image archives of healthcare providers by transforming Real-World
Data into a valuable, quality asset that can help clinicians improve care and lower costs. Employing its proven OneMedNet iRWD
solution, OneMedNet securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party
research opportunities to providers. By leveraging this extensive federated provider network, together with industry leading technology
and in-house clinical expertise, OneMedNet successfully meets the most rigorous Real-World Data Life Science requirements. OneMedNet is
led by its Chief Executive Officer, Paul Casey, its President, Aaron Green, and Founder, Chairman
and Chief Medical Officer, Dr. Jeffrey Yu.
About Data Knights Acquisition Corp.
Data Knights Acquisition Corp. is a blank check
company formed for the purposes of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar
business combination with one or more tech or software businesses or entities.
Important Information
and Where to Find It
This press release relates
to the Business Combination between OneMedNet and Data Knights. This press release does not
constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale
of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under
the securities laws of any such jurisdiction. In connection with the transaction described herein, OneMedNet
and Data Knights, and/or a successor entity of the transaction has filed or will file relevant materials with the SEC, including
an effective Registration Statement on Form S-4, which includes a proxy statement/prospectus of Data Knights, which will be
filed with the SEC promptly following the date of this press release. The definitive proxy statement will be sent to all Data Knights
stockholders. OneMedNet and Data Knights, and/or a successor entity of the transaction will
also file other documents regarding the proposed transaction with the SEC. Before making any voting or investment decision, investors
and security holders of Data Knights are urged to read the Registration Statement, the proxy statement/prospectus and all other relevant
documents filed or that will be filed with the SEC in connection with the proposed transaction as they become available because they will
contain important information about the proposed transaction.
Investors and security
holders will be able to obtain free copies of the Registration Statement, the proxy statement/prospectus and all other relevant documents
filed or that will be filed with the SEC by OneMedNet and Data Knights, or any successor
entity of the transaction through the website maintained by the SEC at www.sec.gov.
documents filed or that will be filed by Data Knights with the SEC also may be obtained
free of charge upon written request to Data Knights Acquisition Corp. Trident Court, 1 Oakcroft
Road, Chessington, Surrey KT9 1BD, United Kingdom or via email at barry@dataknightsacuk.com. The documents filed or that
will be filed by OneMedNet or any successor entity of the transaction with the SEC also
may be obtained free of charge upon written request to SEC at www.sec.gov or by directing a request to OneMedNet,
6385 Old Shady Oak Rd Ste 250, Eden Prairie, MN 55344 or
via email to paul.casey@onemednet.com.
Participants in the Solicitation
OneMedNet, Data Knights
and certain of their respective directors, executive officers and other members of management and employees may, under SEC rules, be deemed
to be participants in the solicitation of proxies from Data Knights' stockholders in connection with the proposed transaction. Additional
information regarding the identity of all potential participants in the solicitation of proxies to data Knights' shareholders in
connection with the Business Combination and other matters to be voted upon at the Special Meeting, and their direct and indirect interests,
by security holdings or otherwise, is set forth in Data Knights' proxy statement. Investors may obtain such information by reading
such proxy statement.
This press release is
for informational purposes only and relates to a proposed business combination between OneMedNet and Data Knights Acquisition Corp
and is not intended and does not constitute a proxy statement or solicitation of a proxy, consent
or authorization with respect to any securities or in respect of the potential transaction and shall not constitute an offer to
sell or a solicitation of an offer or invitation for the sale or purchase of the securities,
assets or the business of Data Knights Acquisition Corp. or OneMedNet, nor shall there be
any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration
or qualification under the securities laws of such state or jurisdiction. No offer of securities